ImmuPharma plc - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

BHP explores a potential $2 billion sale of Chilean desalination and electricity transmission assets supporting its major copper operations. Representative image.

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone shares surge after Xavier Niel’s Vega agrees to acquire e&’s 16.21 percent stake in a £4.4 billion transaction. Representative image.

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers and Micron Technology expand United States semiconductor supply capacity through a $500 million financing and 10-year silicon wafer agreement. Representative image.

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s new long-range strike command intensifies its campaign against Russian oil refineries, fuel infrastructure and wartime logistics networks. Representative image.

Ukraine’s drone war enters new phase with dedicated command targeting Russia

Representative image of autoimmune drug research as ImmuPharma plc seeks a P140 licensing deal and advances Kapiglucagon toward early clinical development.

Read More

Pharma Industry News

ImmuPharma (LSE: IMM) has two biotech catalysts, but can P140 finally deliver the deal?

ImmuPharma targets a P140 licensing deal while LSE trades below its Lanstead benchmark. The next partner decision could reshape the biotech story.

July 10, 2026

web analytics